← Onterris, Inc.
| Annual Trend | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net loss | ($16.5m) | ($23.6m) | ($57.9m) | ($25.3m) | ($31.8m) | ($30.9m) | ($62.3m) | ($843k) | — | |
| Depreciation and amortization | $23.9m | $27.7m | $37.3m | $44.8m | $47.5m | $45.8m | $52.8m | $50.9m | $50.2m | |
| Deferred income taxes | ($5.0m) | ($3.1m) | $851k | $1.7m | $2.2m | ($980k) | $4.3m | $9.9m | $10.3m | |
| Stock-based compensation expense | $5.8m | $4.3m | $4.8m | $10.3m | $43.3m | $47.3m | $64.7m | $42.7m | $36.9m | |
| Accounts receivable and contract assets | ($10.0m) | ($6.6m) | ($19.2m) | ($36.2m) | $4.4m | ($2.9m) | ($42.0m) | ($10.1m) | $32.3m | |
| Accounts payable and other accrued liabilities | ($2.2m) | $6.1m | $601k | $24.0m | ($9.9m) | ($8.9m) | $3.8m | $8.3m | ($8.2m) | |
| Accrued payroll and benefits | $449k | $2.2m | $6.1m | $3.2m | ($6.8m) | $9.5m | ($1.7m) | $18.5m | — | |
| Accrued purchases of property and equipment | $793k | $975k | $432k | $790k | $2.3m | $1.1m | $983k | $1.2m | — | |
| Accrued lease surrender liability | — | — | — | — | — | $5.9m | — | — | — | |
| Other operating activities, net | — | — | — | — | ($4.0m) | $3.1m | $608k | $668k | — | |
| Prepaid expenses and other current assets | ($101k) | ($2.5m) | ($956k) | ($886k) | ($1.8m) | ($918k) | ($552k) | ($3.3m) | — | |
| Other assets | — | ($1.6m) | ($3.2m) | ($262k) | — | — | $378k | $1.3m | — | |
| Net cash provided by operating activities | ($2.8m) |
$17.0m
+699.02%
|
$1.9m
-89.14%
|
$37.6m
+1931.41%
|
$20.6m
-45.05%
|
$56.0m
+171.31%
|
$22.2m
-60.31%
|
$107.5m
+383.36%
|
$74.6m
-30.59%
|
|
| Proceeds from corporate owned and property insurance | — | — | $0 | $413k | $329k | $573k | $224k | — | — | |
| Purchases of property and equipment | ($3.8m) | ($4.7m) | ($7.2m) | ($6.9m) | ($10.0m) | ($29.6m) | ($21.3m) | ($16.3m) | ($20.4m) | |
| Proceeds from the sale of property and equipment | $166k | $260k | $20k | $597k | $174k | $971k | $2.1m | $712k | — | |
| Property and equipment purchased under finance leases | $3.1m | $4.3m | $2.1m | $1.8m | $5.1m | $8.3m | $9.4m | $23.4m | — | |
| Minority investments | — | — | — | — | — | ($2.6m) | ($210k) | — | — | |
| Cash paid for acquisitions, net of cash acquired | ($45.8m) | ($81.4m) | ($173.9m) | ($55.7m) | ($28.6m) | ($66.2m) | ($113.1m) | — | — | |
| Acquisitions unpaid contingent consideration | $4.8m | $5.4m | $54.5m | $35.8m | $8.3m | $6.0m | $33.1m | $17.6m | — | |
| Acquisitions contingent consideration paid in common stock | — | — | — | $26.1m | — | $1.0m | $1.1m | $7.3m | — | |
| Net cash used in investing activities | ($50.3m) | ($87.0m) | ($179.7m) | ($71.6m) | ($38.7m) | ($101.6m) | ($138.0m) | ($15.8m) | ($19.0m) | |
| Proceeds from issuance of common stock for exercised stock options | — | $1.5m | $408k | $7.2m | $1.6m | $4.7m | $2.1m | $1.1m | $0 | |
| Proceeds from issuance of common stock in follow-on offering, net of issuance costs | $30k | $1.5m | $408k | — | — | — | $121.8m | — | $0 | |
| Common stock issued to acquire new businesses | $5.6m | $4.0m | $25.0m | $8.3m | — | $2.6m | $10.7m | — | — | |
| Dividend payment to the series A-2 stockholders | — | — | ($7.0m) | ($16.4m) | ($16.4m) | ($16.4m) | ($11.1m) | ($4.2m) | — | |
| Taxes paid related to net share settlement of equity awards | $596k | $1.2m | $171k | $412k | $789k | $997k | $4.2m | ($10.7m) | — | |
| Net cash provided by (used in) financing activities | $50.9m |
$74.5m
+46.41%
|
$205.9m
+176.56%
|
$146.1m
-29.04%
|
($38.8m)
-126.53%
|
($20.1m)
+48.12%
|
$106.0m
+627.11%
|
($93.1m)
-187.85%
|
($53.6m)
+42.45%
|
|
| Change in cash, cash equivalents and restricted cash | ($2.3m) | $4.5m | $28.0m | $112.0m | ($56.8m) | ($65.7m) | ($9.8m) | ($1.5m) | — | |
| Additional Supplementary Disclosures | ||||||||||
| Additional Supplementary Disclosures | ||||||||||
| Provision (recovery) for credit loss | — | — | — | — | — | $3.1m | ($146k) | $6.7m | — | |
| Non-cash leases expense | — | — | — | — | — | $10.2m | $11.6m | $11.8m | — | |
| Fair value changes in financial instruments | ($352k) | $7.1m | $11.0m | $2.2m | ($3.4m) | ($4.1m) | $3.1m | ($18.3m) | — | |
| Write off of deferred financing costs | — | — | — | — | — | — | — | $913k | — | |
| Payment of contingent consideration | — | — | ($6.4m) | ($15.6m) | ($19.5m) | ($611k) | — | — | — | |
| Change in operating leases | — | — | — | ($7.9m) | ($8.9m) | ($10.5m) | ($12.0m) | ($11.8m) | — | |
| Proprietary software development and other software costs | ($337k) | ($21k) | ($570k) | ($699k) | ($593k) | ($3.4m) | ($2.5m) | ($695k) | — | |
| Purchase price true ups | — | — | $1.9m | ($9.3m) | ($389k) | ($1.4m) | ($3.3m) | $458k | — | |
| Proceeds from revolving line of credit | $109.4m | $146.3m | $104.4m | $109.0m | — | — | $403.1m | $477.6m | — | |
| Repayment of the revolving line of credit | ($89.4m) | ($68.7m) | ($202.0m) | ($109.0m) | — | — | ($377.6m) | ($419.8m) | — | |
| Proceeds from the aircraft loan | — | — | — | — | — | $10.9m | — | — | — | |
| Repayment of aircraft loan | — | — | — | — | — | ($591k) | ($1.1m) | ($1.1m) | — | |
| Proceeds from term loan | $35.3m | — | $175.0m | $175.0m | — | — | $50.0m | $200.0m | — | |
| Repayment of term loan | ($71.6m) | ($1.2m) | ($49.8m) | ($173.9m) | ($8.8m) | ($12.2m) | ($15.0m) | ($191.7m) | — | |
| Payment of contingent consideration and other purchase price true ups | ($2.0m) | ($1.1m) | ($6.0m) | ($9.9m) | ($11.1m) | ($1.9m) | ($363k) | ($11.0m) | — | |
| Repayment of finance leases | — | ($2.0m) | ($2.8m) | ($2.7m) | ($4.0m) | ($4.6m) | ($5.5m) | ($11.1m) | — | |
| Payments of deferred financing costs | — | — | ($4.2m) | ($446k) | ($183k) | — | ($348k) | ($2.4m) | — | |
| Proceeds from building sale leaseback | — | — | — | — | — | — | — | $2.5m | — | |
| Redemption of series A-2 Preferred Stock | — | — | — | — | — | — | ($60.0m) | ($122.2m) | — | |
| Foreign exchange impact on cash balance | — | ($116k) | ($15k) | ($183k) | ($111k) | ($876k) | ($497k) | ($224k) | — | |
| Beginning of year | $2.5m | $6.9m | $34.9m | $146.7m | $89.8m | $23.2m | $12.9m | $11.2m | — | |
| Cash paid for interest | $7.9m | $5.9m | $11.9m | $5.0m | $6.5m | $8.1m | $14.8m | $17.9m | — | |
| Cash paid for income tax | $596k | $1.2m | $171k | $412k | $789k | $997k | $4.2m | $5.5m | — | |
| Non-cash considerations received from sale of subsidiary | — | — | — | — | — | — | — | $4.5m | — | |
| Promissory note receivable issued in connection with the sale of assets of the Discontinued Specialty Lab | — | — | — | — | — | $4.3m | — | — | — |